MediCash launched a new medical lending venture in India. It secured a ₹100 crore debt commitment from Assam-based lender Sayyam Investments. The company offers no-cost monthly installments for planned medical procedures.
Debt and equity details
The debt commitment was made in 2026. MediCash also holds ₹5 crore in friends-and-family equity. A further ₹200 crore green-shoe facility is planned to add loan capacity later.
Founder and market need
Founder Himanshu Rajpurohit also started US-based Nexera Health, an employee-benefits startup. He launched MediCash as a separate lending venture for planned medical care in India. Planned treatments are costly for many Indian households.
How the offering works
The platform provides no-cost EMIs for planned procedures. Patients can split medical costs into monthly installments rather than paying all at once. This spreads treatment expenses over time for Indian households.
MediCash plans to raise ₹15-20 crore in equity. The company will pursue that capital after securing the debt commitment from Sayyam Investments. It will support the new medical lending business.
Read more: economictimes.indiatimes.com